Mr. Walton spoke at MDMA’s annual meeting in late May and discussed his experiences as a patient undergoing spinal fusion surgery and the challenges the industry faces, including the medical device excise tax, regulatory struggles with the FDA and reimbursement with CMS. After his speech, Mr. Walton and NuVasive CEO Alex Lukianov traveled to Capitol Hill to lobby lawmakers on these issues.
Related Articles on Medical Devices:
Smith & Nephew Voluntarily Withdraws Hip System Component
Maine Plans Statewide Medical Image Archive Pilot
Amedica Names Brian McEntire Chief Technology Officer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.